Altaroc
Newsroom
etc.
Company

A fast-growing company. Vivacy continues to grow in a booming dermal filler sector

Published on
6/9/2023
Amended on
28/3/2024
0
minute(s)
The dermal filler market is expected to grow by an average of 7.5% between 2023 and 2033, from $5 billion in 2021 to $6.7 billion by 2031. Vivacy, a Rhône-Alpes-based company founded by Waldemar Kita, is a world leader in this field, with sales exceeding 64 million euros in 2022.
By
Damien Hélène
Damien Hélène
This article has been automatically translated. Please excuse any inaccuracies or translation errors.

The dermal filler market is expected to grow by an average of 7. 5% between 2023 and 2033. This is according to a new study by Future Marketing Insights.

The dermal filler market represented $5 billion in 2021. It should exceed $5.2 billion in 2022, reaching $6.7 billion by 2031.

This growth can be explained by the steady rise in demand for facelifts and corrections to certain parts of the face in growth markets such as the United States, Brazil,Germany and Malaysia.

Based in the Rhône-Alpes region, Vivacy has established itself as a world leader in hyaluronic acid-based dermal fillers.

Featured in Vintage Altaroc Odyssey 2022, the company, founded by the Franco-Polish Waldemar Kita, saw its sales exceed 64 million euros in 2022, up 28% year-on-year.

Its products, exported to over 85 countries, are used in non-invasive medical aesthetic procedures. Hyaluronic acid injections are used to fill bags under the eyes, smooth wrinkles and eliminate scars.

No items found.

The latest Hors-Séries

10 revolutionary innovations you didn't know about

7
item(s)

Artificial Intelligence at the service of health

12
item(s)

Environmental, Social and Governance issues, central and strategic pillars of Private Equity

11
item(s)
Newsletter
Subscribe to our newsletter to keep up to date with all the latest news.
No items found.
North America
Healthcare